Two Sigma Securities’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Two Sigma Securities’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,907	Closed	-$12.8K	–	3835
2023 Q4	$12.8K	Buy	1,907 +714	+60%	+$6.28K	﹤0.01%	2787
2023 Q3	$10.9K	Buy	1,193 +607	+104%	+$12.2K	﹤0.01%	2682
2023 Q2	$12.4K	Buy	+586	New	+$18K	﹤0.01%	2566
2023 Q1	–	Sell	-1,070	Closed	-$37.9K	–	3439
2022 Q4	$37.9K	Buy	+1,070	New	+$129K	﹤0.01%	2203

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

AWP

Accretive Wealth Partners Parsippany, New Jersey $356M AUM 14.3% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Two Sigma Securities's EIGR Position: Q1 2024 in Review

Two Sigma Securities sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2024, closing a stake of 1,907 shares — an estimated $12.8K sold.

Two Sigma Securities first reported a position in EIGR in Q4 2022 and held it in 4 quarters. The position peaked at $37.9K in Q4 2022. 24 funds tracked by Wall St. Rank hold EIGR as of Q1 2024.

Two Sigma Securities reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
Two Sigma Securities sold 1,907 Eiger BioPharmaceuticals, Inc. shares in Q1 2024, an estimated $12.8K.
Two Sigma Securities first reported a position in Eiger BioPharmaceuticals, Inc. in Q4 2022 and held it in 4 quarters.
Two Sigma Securities's Eiger BioPharmaceuticals, Inc. position peaked at $37.9K in Q4 2022.
24 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.